HealthQuill Lung Infections
The European Commission has approved Vertex Pharmaceuticals' drug to treat cystic fibrosis in adults and children above six years of age who have certain genetic mutations related to the disease.
Drugs Health Pharma

EC approves Vertex’s once-daily drug combination to treat cystic fibrosis 

HQ Team July 3, 2025:  The European Commission has approved Vertex Pharmaceuticals‘ drug to treat cystic fibrosis in adults and children above six.

Read More
The Cystic Fibrosis Foundation will invest up to $2.3 million in Owlstone Medical to develop a test that is designed to detect Pseudomonas infections from a person’s breath.
Drugs Health Medical

CF Foundation to fund project to find lung infections from people’s breath

HQ Team March 26, 2025: The Cystic Fibrosis Foundation will invest up to $2.3 million in Owlstone Medical to develop a test that.

Read More
The US-based Merck and Co.’s investigational medicine to protect infants from respiratory syncytial virus (RSV) disease has resulted in lowering infections, according to the company.
Drugs Health Pharma

Merck’s experimental RSV injection lowers infections in infants 

The US-based Merck and Co.’s investigational medicine to protect infants from respiratory syncytial virus (RSV) disease has resulted in lowering infections, according to.

Read More